Colonial Trust Advisors’s AbbVie ABBV Stock Holding History
Bought
Maintained
Sold
Other funds holding ABBV
VCM
VPM
Colonial Trust Advisors's ABBV Position: Q1 2026 in Review
Colonial Trust Advisors reduced its AbbVie (ABBV) stake by 3.7% in Q1 2026, selling an estimated $23.5K and leaving 2,786 shares worth $606K. The position accounts for 0.05% of the portfolio, ranked #136.
Colonial Trust Advisors first reported a position in ABBV in Q4 2020 and has held it in 22 quarters since. The position peaked at $661K in Q4 2025. 4,077 funds tracked by Wall St. Rank hold ABBV as of Q1 2026.
- Colonial Trust Advisors held 2,786 shares of AbbVie worth $606K as of Q1 2026.
- Colonial Trust Advisors sold 106 AbbVie shares in Q1 2026, an estimated $23.5K.
- AbbVie made up 0.05% of Colonial Trust Advisors's portfolio in Q1 2026, its #136 holding.
- Colonial Trust Advisors first reported a position in AbbVie in Q4 2020 and has held it in 22 quarters since.
- Colonial Trust Advisors's AbbVie position peaked at $661K in Q4 2025.
- 4,077 funds tracked by Wall St. Rank held AbbVie as of Q1 2026.
Based on Colonial Trust Advisors's 13F filing for Q1 2026, filed 12 May 2026.